Prolactin, 19-nors and the test nobody takes

What a 19-nor is and what progestogenic means Mechanism

A 19-nor compound is a steroid missing the carbon-19 methyl group that testosterone carries. Nandrolone is 19-nortestosterone itself, the parent of the group. Trenbolone is a 19-nor as well. The same 19-nortestosterone skeleton is the parent structure of a family of prescription progestins, including norethisterone and levonorgestrel, which is the chemistry behind the idea that nandrolone has progestin-like effects. Removing that carbon changes how the molecule sits in more than one receptor, which is why these compounds behave differently from testosterone derivatives.

What people mean by progestogenic is binding to the progesterone receptor. Classic receptor work found 19-nortestosterone and several related compounds binding the rabbit uterine progesterone receptor, behaving as mixed agonist-antagonists rather than as clean progestins. Trenbolone, tested against the bovine uterine receptor, bound slightly more strongly than progesterone itself. Both findings come from animal receptors. We found no study measuring what either does at the human progesterone receptor in men, so the size of the effect in a person is unknown.

What the human prolactin data shows Clinical evidence

Community reports commonly blame deca and tren for raising prolactin and blame that for low libido on deca ("deca dick"). Anecdotal The human data behind it is close to absent.

In a Japanese study of 76 men on hemodialysis, the 23 prescribed an anabolic steroid (mepitiostane or nandrolone decanoate) had lower testosterone than the others, but their prolactin did not differ. In castrated sheep, trenbolone acetate implants left plasma prolactin unchanged. A 2024 study of 30 Baghdad bodybuilders using steroids including testosterone, boldenone and Deca found higher prolactin than in 30 non-users. It could not separate one compound from another. Stacks like these usually contain several.

None of that proves 19-nors never raise prolactin. It means the claim is unproven, so treating it as a certainty and medicating against it blind is not supported by evidence. A prolactin test answers the question for one person.

Progestogenic activity is not the same as high prolactin Mechanism

Here is the conflation that drives most of the confusion and most of the unnecessary medication.

Gynecomastia tissue almost always carries progesterone receptors: 98% of samples in one large tissue study. That is the usual explanation for gynecomastia developing on a 19-nor while estradiol looks unremarkable, though in men it is inferred rather than measured. Serum prolactin is a separate thing, a hormone made by the anterior pituitary under dopamine control. The two get treated as one. Only one of them is a blood test you can order for very little money.

What happens in practice is that someone on nandrolone notices sore or puffy nipples, reads that 19-nors raise prolactin, concludes they have prolactin gynecomastia then starts a dopamine agonist. Prolactin was never measured. It might have been normal. The symptom might have been estrogenic. The drug they reached for treats one specific cause, so if that cause was absent it brings only its side effects.

The general workup for a raised prolactin, including the macroprolactin trap and the draw conditions that produce false highs, is covered on prolactin in men. Worth reading before any number becomes a decision, because a wrong number leads to a wrong drug as reliably as no number does.

Cabergoline versus pramipexole Drug labelClinical evidence

Both are dopamine agonists. They are not equivalent choices.

Cabergoline is a long-acting D2 agonist whose US label covers hyperprolactinemic disorders, idiopathic or from a pituitary adenoma. It is first-line treatment for most patients with prolactin-secreting tumors. Confirmed, symptomatic high prolactin from such a tumor is usually managed with a dopamine agonist such as cabergoline; a raised prolactin caused by a medication is handled differently. Speak to a clinician. A raised prolactin needs its cause found first, which is what the workup above is for.

Anabolic users also take cabergoline off-label, often to counter suspected 19-nor side effects; whether 19-nors raise prolactin in men is not established, so test prolactin first and speak to a clinician. Off-label use In a 2020 survey of 2,385 men using anabolic steroids, 266 (about 1 in 9) reported taking cabergoline or bromocriptine during a cycle. A 2025 analysis of seized products found cabergoline among the ancillary drugs sold alongside steroids, some of it mislabeled.

Pramipexole is a dopamine agonist labeled for Parkinson's disease and restless legs syndrome. It lowers prolactin, as dopamine agonists do, but hyperprolactinemia is not on its label. Choosing it over cabergoline means choosing the drug with less evidence in the condition being treated.

Impulse-control problems belong to both. Hypersexuality, binge eating, compulsive spending or gambling are a class effect of dopamine agonists; the cabergoline label lists gambling, hypersexuality and compulsive spending. A 2025 review put their prevalence at 7.5 to 46% across studies of people treated for hyperprolactinemia, with cabergoline implicated more often than bromocriptine and younger patients and men at higher risk.

The valve question deserves precision rather than reassurance or alarm. Cabergoline at the high doses once used in Parkinson's disease caused a characteristic restrictive valve disease, which is why that use was largely abandoned. Whether the far smaller hyperprolactinemia doses carry the same risk was addressed by a 2019 meta-analysis of 13 case-control studies of patients treated for at least six months. It found more tricuspid regurgitation on cabergoline than in controls, with an odds ratio of 3.74. In no patient was tricuspid dysfunction diagnosed from symptoms. No other valve problem increased. A 2021 study of 646 prolactinoma patients in primary care found no increase in valve surgery or heart failure against matched controls.

That is not the same as harmless. A fatal case of cabergoline-associated tricuspid valve disease has been published in a prolactinoma patient, at cumulative doses and durations beyond what the surveillance studies covered. The US label asks for a cardiovascular evaluation including an echocardiogram before treatment, which is exactly the monitoring someone self-sourcing does not get. Read honestly, this argues against standing prophylaxis and for any use being decided by a clinician against a measured problem.

Three things that move this out of self-management Clinical evidence

Breast tissue that is firm, one-sided or growing needs examining rather than medicating. Not every cause is a drug: the list includes testicular tumors, thyroid disease and, rarely, breast cancer, which a careful examination usually tells apart. Gynecomastia that does not resolve can need surgery.

New or worsening headache, or any change in peripheral vision, alongside a raised prolactin needs a clinician promptly, since a pituitary cause has to be ruled out.

New compulsive behavior on any dopamine agonist, meaning gambling, spending, hypersexuality or binge eating, is a recognized drug effect. It needs a clinician involved. The cabergoline label says it has generally reversed when the dose was reduced or the drug stopped; the pramipexole label reports the urges stopped in some, but not all, cases once the dose was reduced or the drug stopped.

What the calculator flags and what it cannot Mechanism

The cycle calculator marks a 19-nor in the stack, because that is a structural fact about the molecule you selected. The stack checker also flags a combination that catches people out: a 5-alpha reductase inhibitor alongside nandrolone. In rat and cell studies, 5-alpha reduction turns testosterone into DHT, which binds the androgen receptor more strongly, but turns nandrolone into dihydronandrolone, which binds it less strongly. Blocking the enzyme may therefore leave more of the stronger molecule in play. There is no human study of the combination, so the checker shows it as thin evidence.

What no calculator can tell you is your prolactin. That is a blood test, it is inexpensive and it is the only thing on this page that turns a guess into a decision.